Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 9, 2010

View Archived Issues

Indian scientists claim new inhibitors of TNF-alpha production

Cornerstone Pharma adds new site for phase I/II CPI-613 trials in cancer

Southern Research Institute discloses novel antiviral agents

MannKind discloses new agents for pulmonary drug delivery

Mallinckrodt discovers new diagnostics for renal disorders

Novavax's influenza VLP vaccine triggers cytotoxic T-cell proliferation and IFN-gamma secretion

Clinical data presented on abciximab vs. eptifibatide in PCI

BPR-0912 exhibits antiobesity effects in vivo

Lundbeck identifies highly selective M1 receptor agonist

Lpath provides update on four drug development programs

Galapagos acquires full rights to GLPG-0634 for arthritis

FDA grants fast track status to ACE-031 in Duchenne's muscular dystrophy

Agennix presents update on talactoferrin in cancer and severe sepsis

GlaxoSmithKline presents new antimycobacterial agents

Elder Pharmaceuticals discovers new glucose-lowering agents

Cell Therapeutics reports on second quarter 2010

Italian scientists identify new EGFR inhibitors

Clavis advances phase II gemcitabine elaidate trial in pancreatic cancer

GenVec and Novartis expand collaboration on hearing loss and balance disorders

Impax Laboratories and Perrigo collaborate on topical drug products

FDA to complete review of lorcaserin NDA in October

Glycotope begins phase I trial of GT-MAb 5.2-GEX in cancer

FDA does not grant orphan drug status to Levulan PDT for SCC prevention

FDA approves update of Isentress label with 96-week data of trials in HIV-1 infection

Sunesis partners for phase III VALOR trial of vosaroxin in AML

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...